Skip to content Skip to footer

Emerging Trends in North America’s Hospital Disinfectant Market: A Comprehensive Review

Emerging safety concerns and stringent regulatory measures are predicted to drive the demand for hospital disinfectant products in North America. According to Transparency Market Research Inc., the North American hospital disinfectant products market was valued at US$ 3.1 billion in 2022 and is forecasted to reach US$ 5.4 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.3%.

The influx of international travel has enhanced the globalization of diseases, leading to heightened concerns about the spread of infectious agents and the consequential need for effective disinfectants in healthcare facilities globally. Healthcare providers prioritize patient safety, and employing disinfectant products substantially mitigates the risk of infection, thus securing a safe medical treatment environment. To illustrate this point, the American Health Association approximated that nearly 33 million individuals were hospitalized in 2022.

Research and development pertaining to hospital disinfectant products is concentrated in North America. Companies in this region aim to expand their product portfolios and acquire other companies to exploit lucrative revenue opportunities. Some key players in this domain include Colgate-Palmolive Company, Ecolab Inc., Johnson & Johnson, The Procter & Gamble Company, 3M Company, and others.

In light of new and emerging infectious diseases, the necessity for an effective infection control program has become more pronounced. This requirement underlines the importance of disinfecting healthcare facilities to counteract threats from pandemics and epidemics. According to the report, the United States was found to be the most dominant in the North American hospital disinfectant market in 2022. Hospitals are likely to surge their demand for liquid disinfectants, and the disinfectant industry is projected to witness an increased demand for medium-priced products.

Infections related to healthcare provision are a key driving factor of the hospital disinfectant products market. Regulatory agencies, such as the U.S. Environmental Protection Agency (EPA) and the European Chemicals Agency (ECHA), enforce strict rules on disinfectant products. These products must meet specific safety and efficacy standards to comply with these regulations.

Disinfectant product sales are expected to rise due to an overall growth in global healthcare expenditure. Healthcare providers can adhere to high standards of hygiene by investing in high-quality disinfectants. Moreover, public health initiatives encourage infection prevention and control, which further increase the demand for effective disinfectant products.

The sales of disinfectant products for hospitals in North America are anticipated to experience significant growth. This increase can be attributed to heightened infection control measures, the contribution of market players, the prevalence of chronic diseases, and a rise in hospital stays and surgeries. Tighter regulatory frameworks are also predicted to contribute to this increase. Future developments in this market include the launch of new products and acquisition of companies to enhance market presence.


Sign Up to Our Newsletter

Be the first to know the latest updates

[yikes-mailchimp form="1"]